The Health Care Select Sector SPDR Fund (XLV) offers investors low-cost, passive exposure to large-cap U.S. health care companies. As of the latest data, XLV charges a 0.10% expense ratio and pays a quarterly distribution that equates to a 1.5% annual yield. The fund trades at a 19.94x forward price-to-earnings ratio, a multiple roughly in line with its five-year average of 19.5x. With top holdings including Johnson & Johnson, UnitedHealth Group and Pfizer, XLV’s market-cap weighting ensures broad exposure to pharmaceuticals, health care equipment and managed care. This positioning makes it a core allocation for investors seeking steady income coupled with potential upside from mean reversion in sector valuation.

Healthcare employment rose by 65,000 positions in December, outpacing the 45,000 gain in retail and reflecting sustained demand for medical services. This growth supports revenue trajectories for XLV’s constituents, particularly hospital operators and outpatient services firms. The sector’s 12-month forward revenue growth consensus is 7.2%, compared with 5.6% for the broader S&P 500. As demographic trends—such as an aging population—drive utilization, XLV stands to benefit from both durable cash flows and incremental pricing power. Investors monitoring sector rotation may view XLV as an attractive alternative to cyclical areas that underperformed in the second half of 2025.